drugset / Trial / NCT03751735
Efficacy of Wharton Jelly in Erectile Dysfunction
NaSingle-groupOpen-labelTreatment
Summary
Efficacy of Intracavernous injection of Wharton jelly Mesenchymal stem cells for the treatment of erectile dysfunction in diabetic patients.
Timeline
- Start
- 2017-01-27
- Primary completion
- 2019-01-13
- Completion
- 2019-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Wharton Jelly Mesenchymal stem cells | Cell therapy | 20 cells | Other |